View in EDS HTML Full Text PDF Full Text

Nonclinical Development of ENV905 (Difluprednate) Ophthalmic Implant for the Treatment of Inflammation and Pain Associated with Ocular Surgery.

Saved in:
Bibliographic Details
Title: Nonclinical Development of ENV905 (Difluprednate) Ophthalmic Implant for the Treatment of Inflammation and Pain Associated with Ocular Surgery.
Authors: Verhoeven RS; 1 Envisia Therapeutics, Durham, North Carolina., Garcia A; 1 Envisia Therapeutics, Durham, North Carolina., Robeson R; 1 Envisia Therapeutics, Durham, North Carolina., Gilger BC; 2 Powered Research , Morrisville, North Carolina., Culp D; 2 Powered Research , Morrisville, North Carolina., Struble C; 3 Covance, Madison, Wisconsin., Hamm L; 4 Intertek Pharmaceutical Services, San Diego, California., Navratil T; 1 Envisia Therapeutics, Durham, North Carolina., Yerxa B; 1 Envisia Therapeutics, Durham, North Carolina.
Source: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics [J Ocul Pharmacol Ther] 2018 Jan/Feb; Vol. 34 (1-2), pp. 161-169. Date of Electronic Publication: 2017 Jun 26.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Association For Ocular Pharmacology And Therapeutics Country of Publication: United States NLM ID: 9511091 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-7732 (Electronic) Linking ISSN: 10807683 NLM ISO Abbreviation: J Ocul Pharmacol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 28650720
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Nonclinical Development of ENV905 (Difluprednate) Ophthalmic Implant for the Treatment of Inflammation and Pain Associated with Ocular Surgery.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Verhoeven+RS%22">Verhoeven RS</searchLink>; 1 Envisia Therapeutics, Durham, North Carolina.<br /><searchLink fieldCode="AU" term="%22Garcia+A%22">Garcia A</searchLink>; 1 Envisia Therapeutics, Durham, North Carolina.<br /><searchLink fieldCode="AU" term="%22Robeson+R%22">Robeson R</searchLink>; 1 Envisia Therapeutics, Durham, North Carolina.<br /><searchLink fieldCode="AU" term="%22Gilger+BC%22">Gilger BC</searchLink>; 2 Powered Research , Morrisville, North Carolina.<br /><searchLink fieldCode="AU" term="%22Culp+D%22">Culp D</searchLink>; 2 Powered Research , Morrisville, North Carolina.<br /><searchLink fieldCode="AU" term="%22Struble+C%22">Struble C</searchLink>; 3 Covance, Madison, Wisconsin.<br /><searchLink fieldCode="AU" term="%22Hamm+L%22">Hamm L</searchLink>; 4 Intertek Pharmaceutical Services, San Diego, California.<br /><searchLink fieldCode="AU" term="%22Navratil+T%22">Navratil T</searchLink>; 1 Envisia Therapeutics, Durham, North Carolina.<br /><searchLink fieldCode="AU" term="%22Yerxa+B%22">Yerxa B</searchLink>; 1 Envisia Therapeutics, Durham, North Carolina.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229511091%22">Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics</searchLink> [J Ocul Pharmacol Ther] 2018 Jan/Feb; Vol. 34 (1-2), pp. 161-169. <i>Date of Electronic Publication: </i>2017 Jun 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Association+For+Ocular+Pharmacology+And+Therapeutics%22">Association For Ocular Pharmacology And Therapeutics </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9511091 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1557-7732 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210807683%22">10807683 </searchLink><i>NLM ISO Abbreviation: </i>J Ocul Pharmacol Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=28650720
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1089/jop.2016.0195
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 161
    Titles:
      – TitleFull: Nonclinical Development of ENV905 (Difluprednate) Ophthalmic Implant for the Treatment of Inflammation and Pain Associated with Ocular Surgery.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Verhoeven RS
      – PersonEntity:
          Name:
            NameFull: Garcia A
      – PersonEntity:
          Name:
            NameFull: Robeson R
      – PersonEntity:
          Name:
            NameFull: Gilger BC
      – PersonEntity:
          Name:
            NameFull: Culp D
      – PersonEntity:
          Name:
            NameFull: Struble C
      – PersonEntity:
          Name:
            NameFull: Hamm L
      – PersonEntity:
          Name:
            NameFull: Navratil T
      – PersonEntity:
          Name:
            NameFull: Yerxa B
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2018 Jan/Feb
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-electronic
              Value: 1557-7732
          Numbering:
            – Type: volume
              Value: 34
            – Type: issue
              Value: 1-2
          Titles:
            – TitleFull: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
              Type: main
ResultId 1